droxidopa has been researched along with methoxyhydroxyphenylglycol in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (61.54) | 18.7374 |
1990's | 4 (30.77) | 18.2507 |
2000's | 1 (7.69) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kato, M; Matsuura, M; Nankai, M; Okubo, Y; Semba, J; Takahashi, R | 1 |
Ogawa, N; Ujike, H; Yamamoto, M | 2 |
Karai, N; Kato, T; Katsube, J; Katsuyama, M; Nakamura, M | 2 |
Gibson, CJ | 1 |
Semba, J; Takahashi, R | 1 |
Kuroda, H; Nukina, I; Ogawa, N; Ota, Z; Yamamoto, M | 1 |
Cilmi, KM; Hoeldtke, RD; Mattis-Graves, K | 1 |
Soares-da-Silva, P | 1 |
Fujii, S; Hatanaka, Y; Yamamoto, M | 1 |
Kikuchi, K; Nishino, K; Ohyu, H | 1 |
Freeman, R; Goldstein, DS; Holmes, C; Kaufmann, H | 1 |
3 trial(s) available for droxidopa and methoxyhydroxyphenylglycol
Article | Year |
---|---|
Neuroendocrinological effects of L-threo-3, 4-dihydroxyphenylserine (DOPS), a putative norepinephrine precursor, on healthy volunteers.
Topics: Adult; Analysis of Variance; Brain; Droxidopa; Growth Hormone; Humans; Hydrocortisone; Kinetics; Male; Methoxyhydroxyphenylglycol; Prolactin; Serine; Thyrotropin | 1990 |
DL-Threo-3,4-dihydroxyphenylserine does not exert a pressor effect in orthostatic hypotension.
Topics: Adult; Aged; Analysis of Variance; Blood Pressure; Chromatography, High Pressure Liquid; Droxidopa; Drug Evaluation; Female; Humans; Hypotension, Orthostatic; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Normetanephrine; Posture; Serine | 1984 |
Clinical pharmacokinetics of the norepinephrine precursor L-threo-DOPS in primary chronic autonomic failure.
Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Blood Pressure; Catecholamines; Chronic Disease; Diet; Droxidopa; Female; Half-Life; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine | 2004 |
10 other study(ies) available for droxidopa and methoxyhydroxyphenylglycol
Article | Year |
---|---|
Effective treatment of pure akinesia with L-threo-3,4-dihydroxyphenylserine (DOPS): report of a case, with pharmacological considerations.
Topics: Droxidopa; Electromyography; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; MMPI; Movement Disorders; Serine | 1985 |
Effect of L-threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Droxidopa; Drug Therapy, Combination; Glycols; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Parkinson Disease; Serine | 1986 |
Effect of L-threo-3,4-dihydroxyphenylserine(L-threo-DOPS) on brain and serum MHPG levels in mice: evidence for NE formation in CNS.
Topics: Animals; Benserazide; Brain; Brain Chemistry; Dose-Response Relationship, Drug; Droxidopa; Glycols; Male; Methoxyhydroxyphenylglycol; Mice; Norepinephrine; Serine | 1987 |
Studies on the activity of L-threo-3,4-dihydroxyphenylserine (L-DOPS) as a catecholamine precursor in the brain. Comparison with that of L-dopa.
Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Brain; Catecholamines; Dopamine; Droxidopa; Kinetics; Levodopa; Male; Methoxyhydroxyphenylglycol; Mice; Nialamide; Norepinephrine; Protein Precursors; Rats; Rats, Inbred Strains; Serine; Substrate Specificity | 1987 |
Increase in norepinephrine turnover after tyrosine or DL-threo-3,4-dihydroxyphenylserine (DL-threo-DOPS).
Topics: Animals; Benzylamines; Brain; Droxidopa; Male; Methoxyhydroxyphenylglycol; Mice; Norepinephrine; Serine; Tyrosine | 1988 |
The effects of L-threo-dihydroxyphenylserine on norepinephrine metabolism in rat brain.
Topics: alpha-Methyltyrosine; Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain; Carbidopa; Droxidopa; Fusaric Acid; Male; Methoxyhydroxyphenylglycol; Methyltyrosines; Norepinephrine; Rats; Rats, Inbred Strains; Reserpine; Serine | 1985 |
Improvement in freezing phenomenon of Parkinson's disease after DL-threo-3, 4-dihydroxyphenylserine.
Topics: Aged; Benserazide; Droxidopa; Gait; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Parkinson Disease; Serine | 1984 |
Preferential decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat renal tissues.
Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Benserazide; Droxidopa; Heart Ventricles; Jejunum; Kidney; Kidney Cortex; Liver; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Oxidopamine; Rats; Rats, Wistar | 1993 |
Result of long-term administration of L-threo-3,4-dihydroxyphenylserine in patients with pure akinesia as an early symptom of progressive supranuclear palsy.
Topics: Antiparkinson Agents; Droxidopa; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Supranuclear Palsy, Progressive | 1997 |
L-DOPS-Accelerated recovery of locomotor function in rats subjected to sensorimotor cortex ablation injury: pharmacobehavioral studies.
Topics: Animals; Benserazide; Brain; Cerebral Cortex; Dopamine Agents; Droxidopa; Drug Therapy, Combination; Levodopa; Male; Methoxyhydroxyphenylglycol; Motor Activity; Norepinephrine; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Stroke | 1999 |